Alivus Life Sciences Limited (NSE:ALIVUS)
India · Delayed Price · Currency is INR 1,048.00
-7.50 (-0.71%)
Jun 1, 2026, 3:30 PM IST
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 129.55 billion as of June 1, 2026. Its market cap has decreased by -5.30% in one year.
Market Cap
129.55B
Enterprise Value
122.29B
Revenue
25.52B
Ranking
n/a
PE Ratio
23.00
Stock Price
1,048.00
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 129.55B, an increase of 41.26%. That is a compound annual growth rate of 7.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 129.55B | 15.21% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | 91.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 321.54B |
| Piramal Pharma | 229.44B |
| Eris Lifesciences | 193.86B |
| NATCO Pharma | 181.96B |
| Cohance Lifesciences | 165.08B |
| Alembic Pharmaceuticals | 144.69B |
| Strides Pharma Science | 102.48B |
| Sudeep Pharma | 83.82B |